> Skip repeated content

Location of the Median Nerve in Carpal Tunnel Spasticity in Patients with Hemiplegic Cerebral Palsy

IRB Number: 29126

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Michelle G. Carlson, MD



Thedore T. Miller, MD, FACR
Gregory R. Saboeiro, MD
Lorene Janowski, Occupational Therapist
Tracy Klein




This research is an observational study on the median nerve positioning in the affected hand/arm of people with hemiplegic cerebral palsy to see if it differs from the general population. Fifteen patients will be enrolled, beginning in 2010.  Patients will undergo an ultrasound on the affected arm.  For patients with typical positioning of the median nerve, there is no follow-up.  For other patients, follow-up is undetermined.

Inclusion/Exclusion Criteria

Inclusion Criteria:

·        Diagnosis of hemiplegic Cerebral Palsy with flexor tendon spasticity

·        Patient of the principal investigator

·        Age 2 years and older

·        Able to understand the informed consent and sign consent/assent for themselves

Exclusion Criteria

·        Prior surgeries on affected arm

·        Patients who are unable to understand the informed consent and sign the consent/assent for themselves

Contact Information

Tracy Klein